Journavx is the first truly new painkiller approved by the Food and Drug Administration in more than 20 years. But the drug is expensive, and many people can't get it yet.

If you need a new vacuum, you can save on a high-quality model during Amazon's big saleWe've scoured through over a thousand Prime Day vacuum deals to find you the best ones.By Pang-Chieh HoIf ...

Vertex Pharmaceuticals is currently pushing against the $467.85 resistance level as its stock maintains an upward trend.

Gemini CLI is your go-to terminal tool for debugging code, managing files, or writing scripts directly from your terminal.

Quantum mechanics has a reputation that precedes it. Virtually everyone who has bumped up against the quantum realm, whether ...

PGIM Jennison Health Sciences Fund’s Q1 2025 letter highlights mixed sector returns, with Vertex Pharmaceuticals in focus.

There are so many products that you can suddenly afford because of these deals. Amazon Canada 's Prime Day sale is happening ...

PGIM Jennison Health Sciences Fund released its first quarter 2025 investor letter. A copy of the letter can be downloaded ...

The success of Vertex's opioid alternative Journavx could aid a group of biotechs that aim to take a similar path with NaV1.8 ...

According to Benzinga Pro, Vertex Pharmaceuticals's peer group average for short interest as a percentage of float is 6.62%, which means the company has less short interest than most of its peers. Did ...

Vertex Pharmaceuticals (NASDAQ:VRTX) is scheduled to announce its earnings on Monday, May 5, 2025. For event-driven traders, understanding historical stock performance around earnings releases can ...

Google Cloud's updated its Vertex AI platform to support AI agents with including the Agent Development Kit, the Agent2Agent protocol, Agent Engine, and Agentspace ...